surmount-2 tirzepatide type 2 diabetes weight loss results 2023 2024 Body reduction in women treated with by reproductive stage: a post hoc analysis from the SURMOUNT program - Tchang - 2025 - Obesity Tirzepatide Delivers in SURMOUNT-2 -

Genital Infections with Sodium Glucose Cotransporter-2 Inhibitors: Occurrence and Management in Patients with Type 2 Diabetes Mellitus

The differences are significant, though context matters when interpreting them

Receive your prescription : Get your Zepbound or Mounjaro prescription sent directly to your preferred pharmacy, ready for pickup

Limitations of this study included the predominantly white demographic, which may potentially limit the generalizability of the results to more diverse populations

The specific amount of weight you might lose from Zepbound is uncertain, but significant weight loss ranging from 35.5 lb (16.1 kg) to 52.0 lb (23.6 kg) was observed in the 72-week SURMOUNT-1 clinical trial, which compared different Zepbound (tirzepatide) doses to a placebo (inactive treatment)